Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer

Patent

Description

Compositions suitable for use as ovarian cancer and/or tumor adjuvants in the preparation of ovarian cancer vaccines, particularly those vaccines useful in the treatment of human ovarian cancer, are provided. The ovarian cancer adjuvants described are comprised of an extracellular matrix material, such as small intestinal submucosal (SIS) tissue. The preparations may take the form of sheets, gels, liquids (injectable), tracer, or other solid or semi-solid preparation. Also disclosed are ovarian tumor inhibiting compositions that include extracellular matrix tissue adjuvants.

Attributes

Attribute NameValues
Title
  • Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer

Patent Number
  • US 8846059 B2

USPTO Link
Inventor
  • Mark A. Suckow

  • William R. Wolter

Inventor From Local Institution
  • Mark A. Suckow

  • William R. Wolter

Other Application
  • 12/633,152

Prior Publication Date
  • 2011-06-09

Prior Publication Number
  • US 20110135690 A1

Claims
  • 14

Classification (US Patent)
  • 424/277.1; 424/423; 424/443; 424/484; 424/489

Cooperative Patent Classification codes
  • A61K 39/0011 (20130101); A61K 2039/55588 (20130101)

International Patent Classification codes
  • A61K 9/00 (20060101); A61K 9/70 (20060101); A61K 9/14 (20060101)

Language
  • English

Date Issued
  • 2014-09-30

Publisher
  • U.S. Patent and Trademark Office

Assignee
  • University of Notre Dame du Lac

Record Visibility and Access Public
Content License
  • All rights reserved

Departments and Units
Member of

Collections

Collections Featuring this Patent
Notre Dame Patents

Files

Please Note: You may encounter a delay before a download begins. Large or infrequently accessed files can take several minutes to retrieve from our archival storage system.